Friday, July 10, 2026

pharma · Haemophilia A · Still's Disease, Juvenile Onset

Swedish Orphan Biovitrum

News and analysis for Swedish Orphan Biovitrum on NovaPharmaNews — regulatory, clinical, and market coverage.

Stockholm, JP HQ
2020 Founded
6 Employees
EMA registrant Type
Company details
Status
Public
HQ
Stockholm, JP
Founded
2020
Employees
6
Programs
7
Drugs
12
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Swedish Orphan Biovitrum — regulatory, clinical, and market coverage.

News and analysis for Swedish Orphan Biovitrum on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Swedish Orphan Biovitrum yet.

Back to company overview →